← Viswa Colluru

What podcasts say about Viswa Colluru

Every statement, with the speaker, the exact quote and the moment it was said.

What Viswa Colluru has said on podcasts

17 statements · 6 positive · 7 negative · 4 neutral

  1. on Biological compoundsNeutralSep 25, 2026· TBPN

    Only a small fraction of biological compounds have been discovered

    “it's expected that there's about 1 to 10 billion.”

    Listen at 1:45:14

    Open the episode · 4 Tech Arguments (Number 3 Will Shock You), Mansion Section, John Arnold Joins | Viswa Colluru, Jake Adler, Adam Korsunsky
  2. on Pharmaceutical companiesPositiveSep 25, 2026· TBPN

    Large impactful drug companies must develop important medicines

    “if you want to build a large and impactful drug company, the rule is super simple. Make drugs and make drugs that matter.”

    Listen at 1:46:42

    Open the episode · 4 Tech Arguments (Number 3 Will Shock You), Mansion Section, John Arnold Joins | Viswa Colluru, Jake Adler, Adam Korsunsky
  3. on cancerNeutralSep 25, 2026· TBPN

    Cancer comprises thousands of distinct diseases

    “cancer isn't one disease. Yeah. And it's... thousands of diseases.”

    Listen at 1:47:36

    Open the episode · 4 Tech Arguments (Number 3 Will Shock You), Mansion Section, John Arnold Joins | Viswa Colluru, Jake Adler, Adam Korsunsky
  4. on Common diseasesNegativeSep 25, 2026· TBPN

    Common diseases are difficult to treat because they are complex and multifactorial

    “Common diseases are difficult for two reasons. They're complex and multifactorial.”

    Listen at 1:48:13

    Open the episode · 4 Tech Arguments (Number 3 Will Shock You), Mansion Section, John Arnold Joins | Viswa Colluru, Jake Adler, Adam Korsunsky
  5. on GLP-1 receptor agonistNegativeSep 25, 2026· TBPN

    Approximately 10–15% of patients do not respond to GLP-1 drugs.

    “10 to 15 percent of patients don't respond to GLP-1s.”

    Listen at 1:48:50

    Open the episode · 4 Tech Arguments (Number 3 Will Shock You), Mansion Section, John Arnold Joins | Viswa Colluru, Jake Adler, Adam Korsunsky
  6. on GLP-1 receptor agonistNegativeSep 25, 2026· TBPN

    Ten to fifteen percent of patients do not respond to GLP-1 drugs

    “10 to 15 percent of patients don't respond to GLP-1s.”

    Listen at 1:48:50

    Open the episode · 4 Tech Arguments (Number 3 Will Shock You), Mansion Section, John Arnold Joins | Viswa Colluru, Jake Adler, Adam Korsunsky
  7. on EnvedaNeutralSep 25, 2026· TBPN

    Enveda has not yet begun cancer-treatment efforts

    “we haven't started efforts on trying to treat cancer yet.”

    Listen at 1:50:12

    Open the episode · 4 Tech Arguments (Number 3 Will Shock You), Mansion Section, John Arnold Joins | Viswa Colluru, Jake Adler, Adam Korsunsky
  8. on Enveda drug candidatesPositiveSep 25, 2026· TBPN

    Enveda’s first two drugs target asthma, eczema, and post-GLP-1 weight management

    “Our first two drugs are hitting exactly those problems.”

    Listen at 1:50:51

    Open the episode · 4 Tech Arguments (Number 3 Will Shock You), Mansion Section, John Arnold Joins | Viswa Colluru, Jake Adler, Adam Korsunsky
  9. on Enveda second moleculePositiveSep 25, 2026· TBPN

    Enveda’s second molecule aims to help 55 million Americans after GLP-1 use

    “giving 55 million people in America an off-ramp over the next seven years that will have taken a GLP-1”

    Listen at 1:51:24

    Open the episode · 4 Tech Arguments (Number 3 Will Shock You), Mansion Section, John Arnold Joins | Viswa Colluru, Jake Adler, Adam Korsunsky
  10. on AI-designed chemistryNeutralSep 25, 2026· TBPN

    At least 99% of AI-designed chemistry is constrained by physical feasibility.

    “99% or more of the chemistry that any particular model comes up with is constrained by the physics and energetics of putting it together.”

    Listen at 1:52:53

    Open the episode · 4 Tech Arguments (Number 3 Will Shock You), Mansion Section, John Arnold Joins | Viswa Colluru, Jake Adler, Adam Korsunsky
  11. on AI systemsNegativeSep 25, 2026· TBPN

    AI currently performs poorly at manipulating physical-world processes.

    “AI is really bad at moving things in the physical world.”

    Listen at 1:53:21

    Open the episode · 4 Tech Arguments (Number 3 Will Shock You), Mansion Section, John Arnold Joins | Viswa Colluru, Jake Adler, Adam Korsunsky
  12. on Pilgrim biotechnology platformPositiveSep 25, 2026· TBPN

    Pilgrim aims to deploy biotechnology technologies to warfighters quickly

    “the idea really is to build up what is a really substantial wedge and get technologies like this into the hands of the warfighter today.”

    Listen at 1:56:08

    Open the episode · 4 Tech Arguments (Number 3 Will Shock You), Mansion Section, John Arnold Joins | Viswa Colluru, Jake Adler, Adam Korsunsky
  13. on Biological-security incidentsNegativeSep 25, 2026· TBPN

    Biological-security incidents have increased dramatically

    “the rate and the incidents around bio have grown dramatically”

    Listen at 1:57:52

    Open the episode · 4 Tech Arguments (Number 3 Will Shock You), Mansion Section, John Arnold Joins | Viswa Colluru, Jake Adler, Adam Korsunsky
  14. on Pilgrim Argus platformPositiveSep 25, 2026· TBPN

    Pilgrim’s platform will autonomously detect viruses across multiple media

    “the core platform being able to detect viruses autonomously, that's just going to be deployed across all of these different types of media, wastewater, clinical, everything.”

    Listen at 1:59:55

    Open the episode · 4 Tech Arguments (Number 3 Will Shock You), Mansion Section, John Arnold Joins | Viswa Colluru, Jake Adler, Adam Korsunsky
  15. on Pilgrim ArgusPositiveSep 25, 2026· TBPN

    Pilgrim’s platform will autonomously detect viruses across wastewater, clinical, and other media.

    “the core platform being able to detect viruses autonomously, that's just going to be deployed across all of these different types of media, wastewater, clinical, everything.”

    Listen at 1:59:55

    Open the episode · 4 Tech Arguments (Number 3 Will Shock You), Mansion Section, John Arnold Joins | Viswa Colluru, Jake Adler, Adam Korsunsky
  16. on Airborne biological-threat detectionNegativeSep 25, 2026· TBPN

    Current airborne biological-threat detection takes about a week

    “the current timeline to even detect a threat in the air is like a week.”

    Listen at 2:00:57

    Open the episode · 4 Tech Arguments (Number 3 Will Shock You), Mansion Section, John Arnold Joins | Viswa Colluru, Jake Adler, Adam Korsunsky
  17. on Airborne biological-threat detectionNegativeSep 25, 2026· TBPN

    Current airborne biological-threat detection can take approximately one week.

    “the current timeline to even detect a threat in the air is like a week.”

    Listen at 2:00:57

    Open the episode · 4 Tech Arguments (Number 3 Will Shock You), Mansion Section, John Arnold Joins | Viswa Colluru, Jake Adler, Adam Korsunsky

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.